✦ LIBER ✦

Long-term safety and efficacy of eslicarbazepine acetate in patients with focal seizures: Results of the 1-year ESLIBASE retrospective study

✍ Scribed by Villanueva, V.; Serratosa, J.M.; Guillamón, E.; Garcés, M.; Giráldez, B.G.; Toledo, M.; Salas-Puig, J.; López González, F.J.; Flores, J.; Rodríguez-Uranga, J.; Castillo, A.; Mauri, J.A.; Camacho, J.L.; López-Gomáriz, E.; Giner, P.; Torres, N.; Palau, J.; Molins, A.

Book ID: 122849488
Publisher: Elsevier Science
Year: 2014
Tongue: English
Weight: 387 KB
Volume: 108
Category: Article
ISSN: 0920-1211
DOI: 10.1016/j.eplepsyres.2014.04.014

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Long-term efficacy and safety of eslicar

Long-term efficacy and safety of eslicarbazepine acetate: Results of a 1-year open-label extension study in partial-onset seizures in adults with epilepsy

✍ Peter Halász; Joyce A. Cramer; Danilo Hodoba; Anna Członkowska; Alla Guekht; Joa 📂 Article 📅 2010 🏛 Wiley (Blackwell Publishing) 🌐 English ⚖ 300 KB

Long-term safety and efficacy of eslicar

Long-term safety and efficacy of eslicarbazepine acetate as adjunctive therapy in the treatment of partial-onset seizures in adults with epilepsy: Results of a 1-year open-label extension study

✍ Hufnagel, Andreas; Ben-Menachem, Elinor; Gabbai, Alberto A.; Falcão, Amílcar; Al 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 389 KB

Efficacy and safety of eslicarbazepine a

Efficacy and safety of eslicarbazepine acetate as add-on treatment in patients with focal-onset seizures: Integrated analysis of pooled data from double-blind phase III clinical studies

✍ António Gil-Nagel; Christian Elger; Elinor Ben-Menachem; Peter Halász; José Lope 📂 Article 📅 2012 🏛 Wiley (Blackwell Publishing) 🌐 English ⚖ 389 KB

Efficacy and safety of 800 and 1200 mg e

Efficacy and safety of 800 and 1200 mg eslicarbazepine acetate as adjunctive treatment in adults with refractory partial-onset seizures

✍ A. Gil-Nagel; J. Lopes-Lima; L. Almeida; J. Maia; P. Soares-da-Silva; on behalf 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 200 KB

Long-term evaluation of the efficacy and

Long-term evaluation of the efficacy and safety of loreclezole as add-on therapy in patients with uncontrolled partial seizures: a 1-year open follow-up

✍ T. Rentmeester; A. Janssen; J. Hulsman; F. Scholtes; B. van der Kleij; J. Overwe 📂 Article 📅 1991 🏛 Elsevier Science 🌐 English ⚖ 534 KB

The effect and safety of loreclezole were evaluated during a long-term follow-up trial targeting higher plasma concentrations than those of the preceding controlled trial. The result is better than in the double-blind trial, in which loreclezole doses were administered to reach plasma concentrations

The safety and efficacy of add-on leveti

The safety and efficacy of add-on levetiracetam in elderly patients with focal epilepsy: A one-year observational study

✍ Konrad J. Werhahn; Sven Klimpe; Sonja Balkaya; Eugen Trinka; Günter Krämer 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 232 KB